CURE

Trade Now

Compare

Global X S&P Biotech ETF

1 day chart

Get A$10 trading credit to start you off

T&Cs apply

Claim now

Get A$10 trading credit to start you off

About CURE

The Global X S&P Biotech ETF (CURE) seeks to invest in companies that stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.

Find out what a historical investment in Global X S&P Biotech ETF would be worth today using our CURE stock calculator.

Sector

CEO

Industry

Website

globalxetfs.com.au

Market Capitalisation

$29M

Price-earnings ratio

8.31

Dividend yield

0.00%

High today

$40.75

Low today

$40.67

Open price

$40.67

52-week high

$54.72

52-week low

$38.76

Ready to start your investing journey with Stake?

Open an account

Announcements

CURE FAQs

How do I buy CURE shares in Australia?

Buying CURE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Global X S&P Biotech ETF in minutes.

Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CURE

What is the ticker symbol of Global X S&P Biotech ETF?

The ticker symbol for Global X S&P Biotech ETF is CURE.

How much is one share of CURE?

One share of CURE is valued at $40.75 as of 18 April 2025.

What is the market capitalisation of Global X S&P Biotech ETF CURE?

As of 18 April 2025 Global X S&P Biotech ETF has a market cap of $29M.

What is the P/E ratio of CURE?

The Price to Earnings ratio of CURE is 8.31.

What is the Earnings Per Share of CURE?

The Earnings Per Share of CURE is $4.94.

What is the 52-week high for Global X S&P Biotech ETF stock?

The Global X S&P Biotech ETF 52-week high stock price is $54.72.

What is the 52-week low for Global X S&P Biotech ETF stock?

The Global X S&P Biotech ETF 52-week low stock price is $38.76.

Can I buy CURE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake investing platform allows you to buy CURE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.

This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in CURE
on Stake

Buy CURE from A$3 brokerage

Invest in 2,500+ Aussie stocks and ETFs

CHESS-sponsored ASX trades

Get started

Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.